If you haven`t bought AEHR before the rally:
nor sold the Double Top:
Then analyzing the options chain and the chart patterns of AEHR Test Systems prior to the earnings report this week,
I would consider purchasing the 15usd strike price Calls with
an expiration date of 2024-7-19,
for a premium of approximately $0.98.
If these options prove to be profitable prior to the earnings release, I would sell at least half of them.
nor sold the Double Top:
Then analyzing the options chain and the chart patterns of AEHR Test Systems prior to the earnings report this week,
I would consider purchasing the 15usd strike price Calls with
an expiration date of 2024-7-19,
for a premium of approximately $0.98.
If these options prove to be profitable prior to the earnings release, I would sell at least half of them.
Trade closed: target reached
AEHR trading at $16.28. Those calls are up more than 2X! Still bullish in the chain!Trade closed: target reached
AEHR reached $21.44 after the earnings and the $15 strike price calls skyrocketed more than 6X!
Private SIGNALS patreon.com/PremiumOptionsSignals
Trading COURSE bit.ly/tradex
RESULTS bit.ly/TG10x
TradeNation bit.ly/t10X
CRYPTO partner.bybit.com/b/37880
BUY-SELL INDICATORS tradingindicators.store/
Trading COURSE bit.ly/tradex
RESULTS bit.ly/TG10x
TradeNation bit.ly/t10X
CRYPTO partner.bybit.com/b/37880
BUY-SELL INDICATORS tradingindicators.store/
Related publications
Disclaimer
The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.
Private SIGNALS patreon.com/PremiumOptionsSignals
Trading COURSE bit.ly/tradex
RESULTS bit.ly/TG10x
TradeNation bit.ly/t10X
CRYPTO partner.bybit.com/b/37880
BUY-SELL INDICATORS tradingindicators.store/
Trading COURSE bit.ly/tradex
RESULTS bit.ly/TG10x
TradeNation bit.ly/t10X
CRYPTO partner.bybit.com/b/37880
BUY-SELL INDICATORS tradingindicators.store/
Related publications
Disclaimer
The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.